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Angiogenesis is associated with vascular endothelial
growth factor expression in cervical intraepithelial
neoplasia
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Summary Squamous cell carcinoma of the cervix (SCC) is preceded by a premalignant condition known as cervical intraepithelial neoplasia
(CIN). The majority of cases of CIN regress spontaneously; however, methods are needed to identify those lesions likely to progress.
Increased blood vessel density, signifying angiogenesis, is an independent prognostic indicator in a number of cancers, although little is
known about its significance in premalignant lesions. The aim of the present study was to determine the relationship between vessel density,
expression of the potent angiogenic factor vascular endothelial growth factor (VEGF) and CIN grade. Using immunohistochemistry, mean
vessel density (MVD) and VEGF expression were assessed in samples from 54 patients who had undergone cone biopsy for CIN or
hysterectomy for SCC and from 16 patients with no cervical pathology. There were significant increases in MVD and VEGF expression from
normal cervix through CIN I to CIN IlIl to invasive SCC, but no difference in mean vessel diameter between groups. There was a strong
correlation between mean vessel density and VEGF expression, and both were associated with histological grade of CIN. The original MVDs
for a small group of patients later presenting with recurrent disease were found to be equal to or greater than the mean for their histological
grade. We conclude that the onset of angiogenesis is an early event in premalignant changes of the cervix due, in part, to enhanced
expression of VEGF by the abnormal epithelium.
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Carcinoma of the cervix remains a major cause of mortality and
morbidity in the UK with approximately 4000 new cases diag-
nosed each year. Cervical intraepithelial neoplasia (CIN) is a
precursor to carcinoma of the cervix and is subdivided into three
grades, CIN I, CIN II and CIN III. The malignant potential of the
most severe form, CIN grade III (carcinoma in situ), is thought to
be approximately 36% over 20 years (Mclndoe et al, 1984). Less
is understood about the malignantpotential ofminorCIN (grades I
and II), and up to 50% ofthese lesions may regress spontaneously
(Robertson et al, 1988). There is considerable controversy
surrounding the management of patients with mild abnormalities
(Shafi, 1994), many of which are excised or ablated - treatment
normally recommended for CIN III. Current screening methods
involve Papanicolaou smears and colposcopic referral for smear
abnormalities. Colposcopic examination ofthe cervix relies in part
on identification ofvascular abnormalities, such as punctation and
mosaicism (Sillman et al, 1981), which are indicative of new
blood vessel growth that has penetrated the epithelium.
Angiogenesis is essential for solid tumour growth (Folkman,
1990) and metastasis (Olivarez, 1994). Furthermore, several
studies have now correlated angiogenesis, as indicated by
increased blood vessel density, with poor prognosis in several
types of solid tumour, including those of breast (Weidner et al,
1991, 1992; Horak et al, 1992; Toi et al, 1993; Axelsson et al,
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1995), ofprostate (Weidneret al, 1993) and ofcervix (Schlengeret
al, 1995; Wiggins et al, 1995), and malignant melanoma
(Srivastava et al, 1988). Vascular endothelial growth factor
(VEGF) is akey angiogenic factor andregulator ofendothelial cell
function (Thomas, 1996), acting through two tyrosine kinase
receptors flt-I and KDR (Plate et al, 1994a; Mustonen and Alitalo,
1995). VEGF is expressed during physiological angiogenesis,
including embryological development (Breier et al, 1992), wound
healing (Frank et al, 1995) and in the endometrium (Charnock-
Jones et al, 1993), and also plays a major role in tumour angiogen-
esis (Plate et al, 1992). Underlining the importance of VEGF,
experiments show that tumour growth and metastasis are inhibited
by systemic administration of monoclonal antibodies against
VEGF (Kim et al, 1993) or its receptor KDR (Rockwell and
Goldstein, 1995) and by suppression of normal receptor function
in murine tumour models (Millauer, 1994).
Angiogenesis also occurs in premalignant conditions of breast,
colon and cervix before the onset of frank invasion (Guidi et al,
1994; Bossi et al, 1995; Guidi et al, 1995). Indeed, the occurrence
ofgross vascular changes in CIN III as well as in invasive disease
has been known for many years (Stafl and Mattingly, 1975). Such
changes suggest that the angiogenic process is associated with
progression of intraepithelial neoplasia to invasive SCC. Two
studies have demonstrated that microvessel density increases
progressively with grade of CIN (Smith-McCune and Weidner,
1994; Guidi et al, 1995). More recently, another study (Abulafia et
al, 1996) found no evidence of increased stromal microvessel
count in carcinoma in situ compared with controls, although there
was a significant increase in microinvasive disease. In the current
study, we examine the relationship between MVD, CIN grade and
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Table 1 Patient characteristics
Histological grade Number Mean age (years) Smokers (.%) Mean parity
Control 16 37 33 1.6
CIN 1 15 39 56 1.7
CIN 2 10 38 50 2
CIN3 16 34 50 2
Carcinoma 13 47 60 2.3
expression of VEGF. We have also examined these parameters in
relation to outcome in a small subpopulation of patients who
presented with recurrent disease.
METHODS AND MATERIALS
Study population
Pathology reports on 200 patients who had had cone biopsies or
abdominal hysterectomies for CIN/SCC of the cervix at the
Queen's Medical Centre, Nottingham, during 1989 were reviewed.
Seventy patients were chosen as best representing their respective
histological subgroup and were divided into groups by grade of
CIN or SCC (all invasive carcinomas were stage lb or greater).
Histology was reviewed and blocks selected that showed the best
representative pathology for each patient. Patient characteristics
are summarized in Table 1.
Immunohistochemistry
Formalin-fixed, paraffin-embedded blocks were obtained from the
Pathology Department archives, and 6-jim sections were cut and
mounted on TESPA-coated slides. Sections were deparaffinized,
rehydrated and microwaved on full power in a 650-W microwave
oven to enhance antigen detection. Seventy specimens were
immunostained for von Willebrand factor (vWF) antigen to high-
light endothelial cells lining blood vessels, and 50 of these were
chosen at random for VEGF immunohistochemistry. Slides were
incubated with a 1:3000 dilution of monoclonal antibody against
human vWF (clone F8/86; Dako, High Wycombe, UK) or a 1:500
dilution ofpolyclonal antibody against recombinant human VEGF
(clone A-20; R&D Systems, Abingdon, UK). Antibody binding
was revealed using biotinylated secondary antibodies, avidin-
peroxidase and diaminobenzidine substrate. Slides were counter-
stained with haematoxylin, dehydrated before mounting and
observed with a Nikon Optiphot 2 microscope equipped with
bright-field illumination.
Mean vessel density (MVD)
The vWF-positive blood vessel count was assessed with a x20
objective (plus xIO eyepiece; equal to x200 magnification) using
a square graticule of area 0.25 mm2, positioned beneath the area
of identifiable abnormality. All positive vessels within the grid
were counted. Each specimen had three counts performed
beneath separate areas of histological abnormality by the same
investigator. The MVD was calculated as the mean of these
results per 0.25 mm2. The error for this measurement was
approximately 10%.
Microvessel diameter
Identical slides were used for scoring MVD and vessel diameters.
The diameters often vWF-positive blood vessels per section close
to the basement membrane were measured using computerized
image analysis. The intemal diameterofeach vessel was measured
across the lumen, and the average vessel lumen diameter was
calculated for each specimen.
VEGF staining
Sections stained immunohistochemically with antibodies to VEGF
were scored using an arbitrary scoring system: light or minimal
staining, 1+; moderate staining, 2+; heavy staining, 3+. The
maximumintensity ofVEGF staining was assessed inthe squamous
epithelium. This assessment wasperformedblind andindependently
by two investigators (SPD and PWH). Initially, there was 80%
agreement between investigators; disputed slides were subjected to
a furtherblind assessment by athirdinvestigator (JCM).
Statistical analysis
The MVD (mean number ofvessels per unit area) for each section
was calculated, and the standard error of the mean (s.e.m.)
calculated for each histological group. Statistical analysis was
performed on continuous data using one-way analysis of variance
(ANOVAR; Student-Neuman-Keuls test) to a probability of 5%.
Multiple analysis ofvariance (MANOVAR) was used to assess the
statistical relationship between histological grade, expression of
VEGF and MVD for each section. All analyses were performed
using SPSS-Win version 6.0 software.
RESULTS
Mean vessel density and vessel diameter
A total of70 specimens, representing 16 normal epithelia, 15 CIN
I, ten CIN II, 16 CIN III and 13 invasive SCC, were immuno-
stained with antibody against vWF. These antibodies selectively
stained endothelial cells, allowing identification of blood vessels
in normal and pathological tissues (Figure IA and B). There was a
progressive increase in MVD from normal tissue to invasive SCC,
with a range of vessel counts from a low value of 19 in a normal
sample to 81 vessels perfield in one case ofSCC (Figure 2). There
were significant differences (P < 0.05) between MVD in normal
tissue and all histological grades, as well as significant differences
between CIN III and invasive carcinoma (MVD; 46± 11 and
54 ± 17), and normal epithelium and CIN I (27 ± 4 and 35 ± 7).
Mean vessel diameter increased slightly through the grades ofCIN
and SCC (Table 2), however these changes did not achieve statis-
tical significance.
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Figure 2 Relationship of mean vessel density (MVD) to histological grade of
CIN in five normals and 44 cases of CIN. MVD was determined by counting
the number of von Willebrand factor-positive blood vessels per 0.25mm2
intracellular staining was observed (Figure 3B). Staining was also
seen in macrophages and smooth muscle of arterioles. VEGF
expression was significantly increased (P < 0.05) above that of
control in CIN III and invasive SCC (Table 3).
Association of MVD, VEGF and histological grade
VEGFexpression and MVD showed a strong association (Figure 4)
and werehighlycorrelated by one-way ANOVAR. Multipleanalysis
of variance showed that both histological grade and VEGF expres-
sion were correlated with MVD. If histological grade is excluded,
there is a significant increase in MVD as expression of VEGF
increases (P = 0.007); likewise, when VEGF is excluded, there is a
significant increase in MVD with histological grade (P = 0.024).
Figure 1 Immunostaining for endothelial cells with antibodies against von
Willebrand factor using the immunoperoxidase method. Blood vessel staining
in (A) normal cervix and (B) squamous cell carcinoma. Slides were
counterstained with haematoxylin (magnification x 100)
VEGF expression
Fifty specimens, representing seven normal tissues, 12 CIN I,
eight CIN II, 12 CIN III and 11 invasive SCC, were analysed for
VEGF expression. VEGF staining was seen within the squamous
epithelium and in some cases diffusely within the stroma, however
this staining was very light in normal tissues (Figure 3A). Stronger
staining was noted in dyskaryotic epithelial cells, where granular
Cytological follow-up
The cytological follow-up examinations of the 41 cases of CIN
were traced using the centralized computer database for cytology
at the City Hospital Nottingham. A full 5-year cytological follow-
up was available for25 ofthe 41 patients (61%). Analysis revealed
that complete excision had been achieved with initial treatment in
all of these cases; however, four patients (16%) presented with
recurrent dyskaryosis, with an average time to recurrence of
6 months from initial treatment. The MVDs for three of these
patients were greater than the mean value in the corresponding
CIN group and equal to the mean in the fourth case (Table 4).
Table 2 Mean vessel density (MVD) and histological grade of CIN
Histological grade Number Mean vessel density (MVD) s.e.m. Mean vessel diameter(rm)
Normal 16 27 0.98 13.99
CIN 1 15 36a 1.88 14.99
CIN2 10 39a 3.34 14.19
CIN 3 16 46a,b 2.96 14.74
Invasive SCC 13 54a,b 4.84 15.30
ap<0.05 vs normal. bp<0.05 vs CIN I. Sections from archival samples were stained with monoclonal antibody against von Willebrand
factor to reveal endothelium-lined vessels, and mean vessel density was assessed by counting vessels using a square graticule.
Data are expressed as vessel number per 0.25 mm2. Mean vessel diameter was assessed by measurement using computerized
image analysis. Statistical significance was established using ANOVAR.
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Figure 3 Immunostaining demonstrating VEGF expression in samples of
(A) normal cervical tissue and (B) CIN grade Ill. Samples were stained with
polyclonal antibodies against VEGF by the immunoperoxidase method and
counterstained with haematoxylin (magnification x 100)
DISCUSSION
In cervical carcinoma, the prognostic role of angiogenesis is
unclear; some studies suggest that high blood vessel density
predicts for improved survival when associated with radiotherapy
(Siracka et al, 1994) or intra-arterial chemotherapy (Kohno et al,
1993), while others have found that angiogenesis per se does not
relate to stage ofdisease orprognosis (Bossi et al, 1995, Rutgers et
al, 1995). However, conflicting reports suggest that microvessel
Figure 4 Relationship of vascular endothelial growth factor (VEGF)
expression to mean vessel density (MVD). These parameters were strongly
associated (P = 0.007, MANOVAR)
density is related to vascular space involvement and that high
density is a predictor of tumour recurrence in patients who are
node negative and have no vascular space involvement (Schlenger
et al, 1995; Wiggins et al, 1995).
Several in vitro and in vivo studies have shown that the onset of
angiogenesis occurs before tumour invasion in a variety oftumour
types (Folkman et al, 1989; Guidi et al, 1994; Bossi et al, 1995).
Our data demonstrate that vessel density is significantly increased
in early CIN (grade I) compared with normal tissue, which
suggests that the initiation of the angiogenic process occurs early
in this disease process. Punctation and mosaicism of the epithe-
lium are colposcopic indicators of CIN III, thus gross as well as
microscopic vascular changes are already apparent at a late pre-
malignant stage. However, the presence of gross vascular changes
is unusual in low-grade CIN. The microvascular changes that we
observed in the stroma early in the disease process may represent
precursors ofthose changes seen at later times. We also found that
mean vessel diameter is unchanged irrespective of histological
grade, suggesting that the primary effect of the angiogenic stim-
ulus is to increase vessel number generally, without altering the
distribution ofvessel sizes.
VEGF, an endothelium specific mitogen and potent mediator of
vascular permeability, is expressed in normal tissues, such as
endometrium (Charnock-Jones et al, 1993), and solid tumours
frequently exhibit high levels of VEGF compared with their
normal counterparts (Brown et al, 1993, 1995; Boocock et al,
1995; Wizigmann-Voos et al, 1995). We have demonstrated by
immunohistochemistry that epithelial expression ofVEGF protein
increases with grade of CIN and vessel density. We found
enhanced expression ofVEGF within abnormal areas ofthe squa-
mous epithelium, which concurs with the study of Guidi et al
(1995) that examined expression of VEGF mRNA in CIN by in
situ hybridization. We conclude that the angiogenic process is
mediated by angiogenic factors, particularly VEGF, produced by
abnormal epithelial cells.
Few prognostic indicators for CIN are known; however, lesions
associated with Human Papilloma Virus (HPV) type 16 or 18 are
more likely to progress to severe disease (CIN III) (Woodman
et al, 1996), and most cervical carcinomas are found to have
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Table 3 Expression of VEGF and histological grade of CIN
Histological grade Number Mean vascular density (MVD) VEGF expression
Normal 5 27 0.8
CIN 1 12 37 1.17
CIN2 8 30 0.75
CIN3 13 50 1.69a
Invasive SCC 11 56 2.36a
ap<Q.05 vs normal. VEGF expression in sections from normal and pathological samples was assessed
by immunohistochemistry and scored on an arbitrary scale of 0 to 3+ by two independent
investigators. Data are expressed as mean score for number of samples in each histological group.
Table 4 Cytological recurrence of CIN
Case Histological grade Time to cytological recurrence (months) Mean vascular density (MVD) Mean MVD for group
1 CIN 1 6 52 37
2 CIN 3 6 48 50
3 CIN 3 6 55 50
4 CIN 3 8 65 50
Cytological follow-up of 25 patients with CIN revealed four patients who had presented with recurrent dyskaryosis. The MVD of these patients is shown along
with the MVD for their original histological group.
evidence of HPV infection (Lehtinen et al, 1996). A potential link
between HPV infection and angiogenesis may rest with the p53
tumour-suppressor gene and its relationship to VEGF expression.
E6 protein, associated with HPV subtypes 16 and 18, functionally
inactivates p53 (Huibregtse et al, 1993). One study has suggested
that the presence of functional wild-type p53 suppresses VEGF
expression (Mukhopadhay et al, 1995) and by implication that
VEGF expression may be increased in tumours expressing mutant
p53. Another study suggests that p53 mutation may 'prime'
tumour cells to secrete VEGF in response to other factors (Kieser
et al, 1994). In contrast, Plate et al (1994b) did not find an associa-
tion between VEGF expression and p53 mutation in glioma.
Therefore, while there may in some instances be coincidence of
p53 mutation and VEGF expression, a causal relationship has not
been established. Nevertheless, even if HPV E6 is implicated in
this process, other undefined factors must be involved as not all
patients with CIN III progress to invasive carcinoma and the inci-
dence ofHPV infection in the community is much higher than the
incidence ofCIN. Therefore, the presence ofHPV infection per se
in unlikely to provide information on the probability ofrecurrence
or progression.
In view of the lack of known prognostic indicators, a finding
ofpotential interest is the increasing range of MVD seen within
each histological group. Such a distribution could have
prognostic significance for disease progression. A very small
number ofpatients with recurrent CIN had mean vessel densities
higher than the mean for their group. Although none developed
invasive SCC, four developed further CIN. As it would be
unethical to follow such patients longitudinally, we can only
assume that these patients would be at risk of developing
progressive disease.
Our study conclusively demonstrates an angiogenic change in
premalignant disease of the cervix, associated with an increase in
the expression of the major angiogenic factor VEGF. Further
investigation of the basic mechanism of angiogenesis in CIN is
required to clarify its use in detection and to understand its role in
disease progression.
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